ID ARPC3_HUMAN Reviewed; 178 AA. AC O15145; O00554; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 27-MAR-2024, entry version 192. DE RecName: Full=Actin-related protein 2/3 complex subunit 3; DE AltName: Full=Arp2/3 complex 21 kDa subunit; DE Short=p21-ARC; GN Name=ARPC3; Synonyms=ARC21; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION. RX PubMed=9359840; DOI=10.1042/bj3280105; RA Machesky L.M., Reeves E., Wientjes F., Mattheyse F.J., Grogan A., RA Totty N.F., Burlingame A.L., Hsuan J.J., Segal A.W.; RT "Mammalian actin-related protein 2/3 complex localizes to regions of RT lamellipodial protrusion and is composed of evolutionarily conserved RT proteins."; RL Biochem. J. 328:105-112(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], IDENTIFICATION IN THE ARP2/2 COMPLEX, AND RP SUBCELLULAR LOCATION. RX PubMed=9230079; DOI=10.1083/jcb.138.2.375; RA Welch M.D., Depace A.H., Verma S., Iwamatsu A., Mitchison T.J.; RT "The human Arp2/3 complex is composed of evolutionarily conserved subunits RT and is localized to cellular regions of dynamic actin filament assembly."; RL J. Cell Biol. 138:375-384(1997). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain, and Skin; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP PROTEIN SEQUENCE OF 2-25. RC TISSUE=Platelet; RX PubMed=12665801; DOI=10.1038/nbt810; RA Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., RA Vandekerckhove J.; RT "Exploring proteomes and analyzing protein processing by mass spectrometric RT identification of sorted N-terminal peptides."; RL Nat. Biotechnol. 21:566-569(2003). RN [6] RP RECONSTITUTION OF THE ARP2/3 COMPLEX. RX PubMed=11741539; DOI=10.1016/s1097-2765(01)00393-8; RA Gournier H., Goley E.D., Niederstrasser H., Trinh T., Welch M.D.; RT "Reconstitution of human Arp2/3 complex reveals critical roles of RT individual subunits in complex structure and activity."; RL Mol. Cell 8:1041-1052(2001). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-47, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [8] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-56 AND LYS-61, AND IDENTIFICATION RP BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19608861; DOI=10.1126/science.1175371; RA Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., RA Olsen J.V., Mann M.; RT "Lysine acetylation targets protein complexes and co-regulates major RT cellular functions."; RL Science 325:834-840(2009). RN [9] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25944712; DOI=10.1002/pmic.201400617; RA Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D., RA Lane L., Bairoch A., Van Dorsselaer A., Carapito C.; RT "N-terminome analysis of the human mitochondrial proteome."; RL Proteomics 15:2519-2524(2015). RN [12] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-14, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). RN [13] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=29925947; DOI=10.1038/s41586-018-0237-5; RA Schrank B.R., Aparicio T., Li Y., Chang W., Chait B.T., Gundersen G.G., RA Gottesman M.E., Gautier J.; RT "Nuclear ARP2/3 drives DNA break clustering for homology-directed repair."; RL Nature 559:61-66(2018). CC -!- FUNCTION: Component of the Arp2/3 complex, a multiprotein complex that CC mediates actin polymerization upon stimulation by nucleation-promoting CC factor (NPF) (PubMed:9230079). The Arp2/3 complex mediates the CC formation of branched actin networks in the cytoplasm, providing the CC force for cell motility (PubMed:9230079). In addition to its role in CC the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin CC polymerization in the nucleus, thereby regulating gene transcription CC and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex CC promotes homologous recombination (HR) repair in response to DNA damage CC by promoting nuclear actin polymerization, leading to drive motility of CC double-strand breaks (DSBs) (PubMed:29925947). CC {ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9230079}. CC -!- SUBUNIT: Component of the Arp2/3 complex composed of ACTR2/ARP2, CC ACTR3/ARP3, ARPC1B/p41-ARC, ARPC2/p34-ARC, ARPC3/p21-ARC, ARPC4/p20-ARC CC and ARPC5/p16-ARC. {ECO:0000269|PubMed:11741539, CC ECO:0000269|PubMed:9230079}. CC -!- INTERACTION: CC O15145; P59998: ARPC4; NbExp=4; IntAct=EBI-351829, EBI-351872; CC O15145; P46092: CCR10; NbExp=3; IntAct=EBI-351829, EBI-348022; CC O15145; Q68J44: DUSP29; NbExp=3; IntAct=EBI-351829, EBI-1054321; CC O15145; Q8IZU1: FAM9A; NbExp=3; IntAct=EBI-351829, EBI-8468186; CC O15145; Q08379: GOLGA2; NbExp=6; IntAct=EBI-351829, EBI-618309; CC O15145; O43365: HOXA3; NbExp=6; IntAct=EBI-351829, EBI-8643838; CC O15145; O95835-2: LATS1; NbExp=3; IntAct=EBI-351829, EBI-17978514; CC O15145; P48552: NRIP1; NbExp=3; IntAct=EBI-351829, EBI-746484; CC O15145; P14859-6: POU2F1; NbExp=3; IntAct=EBI-351829, EBI-11526590; CC O15145; Q8NC74: RBBP8NL; NbExp=3; IntAct=EBI-351829, EBI-11322432; CC O15145; Q86VR2: RETREG3; NbExp=5; IntAct=EBI-351829, EBI-10192441; CC O15145; Q9NX95-5: SYBU; NbExp=3; IntAct=EBI-351829, EBI-12816095; CC O15145; A2RTX5: TARS3; NbExp=3; IntAct=EBI-351829, EBI-1056629; CC O15145; O00401: WASL; NbExp=6; IntAct=EBI-351829, EBI-957615; CC O15145; Q9H609: ZNF576; NbExp=3; IntAct=EBI-351829, EBI-3921014; CC O15145; P0DTC9: N; Xeno; NbExp=5; IntAct=EBI-351829, EBI-25475856; CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton CC {ECO:0000269|PubMed:9230079, ECO:0000269|PubMed:9359840}. Cell CC projection {ECO:0000269|PubMed:9230079, ECO:0000269|PubMed:9359840}. CC Nucleus {ECO:0000269|PubMed:29925947}. CC -!- SIMILARITY: Belongs to the ARPC3 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF004561; AAB61466.1; -; mRNA. DR EMBL; AF006086; AAB64191.1; -; mRNA. DR EMBL; CR407667; CAG28595.1; -; mRNA. DR EMBL; BC067747; AAH67747.1; -; mRNA. DR EMBL; BC078162; AAH78162.1; -; mRNA. DR CCDS; CCDS9146.1; -. DR RefSeq; NP_001265485.1; NM_001278556.1. DR RefSeq; NP_001274151.1; NM_001287222.1. DR PDB; 6UHC; EM; 3.90 A; E=1-178. DR PDB; 6YW6; EM; 4.20 A; E=1-178. DR PDB; 6YW7; EM; 4.50 A; E=1-178. DR PDBsum; 6UHC; -. DR PDBsum; 6YW6; -. DR PDBsum; 6YW7; -. DR AlphaFoldDB; O15145; -. DR SMR; O15145; -. DR BioGRID; 115401; 190. DR ComplexPortal; CPX-2490; Actin-related protein 2/3 complex, ARPC1A-ACTR3B-ARPC5 variant. DR ComplexPortal; CPX-2579; Actin-related protein 2/3 complex, ARPC1B-ACTR3-ARPC5 variant. DR ComplexPortal; CPX-2580; Actin-related protein 2/3 complex, ARPC1B-ACTR3B-ARPC5L variant. DR ComplexPortal; CPX-2583; Actin-related protein 2/3 complex, ARPC1B-ACTR3B-ARPC5 variant. DR ComplexPortal; CPX-2586; Actin-related protein 2/3 complex, ARPC1A-ACTR3-ARPC5 variant. DR ComplexPortal; CPX-2592; Actin-related protein 2/3 complex, ARPC1A-ACTR3-ARPC5L variant. DR ComplexPortal; CPX-2663; Actin-related protein 2/3 complex, ARPC1B-ACTR3-ARPC5L variant. DR ComplexPortal; CPX-2668; Actin-related protein 2/3 complex, ARPC1B-ACTR3B-ARPC5L variant. DR CORUM; O15145; -. DR DIP; DIP-33187N; -. DR IntAct; O15145; 95. DR MINT; O15145; -. DR STRING; 9606.ENSP00000228825; -. DR DrugBank; DB08236; (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one. DR DrugBank; DB08235; N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide. DR GlyGen; O15145; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; O15145; -. DR PhosphoSitePlus; O15145; -. DR SwissPalm; O15145; -. DR BioMuta; ARPC3; -. DR OGP; O15145; -. DR EPD; O15145; -. DR jPOST; O15145; -. DR MassIVE; O15145; -. DR MaxQB; O15145; -. DR PaxDb; 9606-ENSP00000228825; -. DR PeptideAtlas; O15145; -. DR ProteomicsDB; 48470; -. DR Pumba; O15145; -. DR TopDownProteomics; O15145; -. DR Antibodypedia; 1504; 283 antibodies from 35 providers. DR DNASU; 10094; -. DR Ensembl; ENST00000228825.12; ENSP00000228825.7; ENSG00000111229.16. DR GeneID; 10094; -. DR KEGG; hsa:10094; -. DR MANE-Select; ENST00000228825.12; ENSP00000228825.7; NM_001278556.2; NP_001265485.1. DR UCSC; uc001tqq.5; human. DR AGR; HGNC:706; -. DR CTD; 10094; -. DR DisGeNET; 10094; -. DR GeneCards; ARPC3; -. DR HGNC; HGNC:706; ARPC3. DR HPA; ENSG00000111229; Low tissue specificity. DR MIM; 604225; gene. DR neXtProt; NX_O15145; -. DR OpenTargets; ENSG00000111229; -. DR PharmGKB; PA25000; -. DR VEuPathDB; HostDB:ENSG00000111229; -. DR eggNOG; KOG3155; Eukaryota. DR GeneTree; ENSGT00390000018018; -. DR HOGENOM; CLU_094365_1_0_1; -. DR InParanoid; O15145; -. DR OMA; TPSKWWL; -. DR OrthoDB; 5485707at2759; -. DR PhylomeDB; O15145; -. DR TreeFam; TF314598; -. DR PathwayCommons; O15145; -. DR Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation. DR Reactome; R-HSA-3928662; EPHB-mediated forward signaling. DR Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs. DR Reactome; R-HSA-8856828; Clathrin-mediated endocytosis. DR Reactome; R-HSA-9664422; FCGR3A-mediated phagocytosis. DR SignaLink; O15145; -. DR SIGNOR; O15145; -. DR BioGRID-ORCS; 10094; 493 hits in 1152 CRISPR screens. DR ChiTaRS; ARPC3; human. DR GeneWiki; ARPC3; -. DR GenomeRNAi; 10094; -. DR Pharos; O15145; Tbio. DR PRO; PR:O15145; -. DR Proteomes; UP000005640; Chromosome 12. DR RNAct; O15145; Protein. DR Bgee; ENSG00000111229; Expressed in monocyte and 111 other cell types or tissues. DR ExpressionAtlas; O15145; baseline and differential. DR GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc. DR GO; GO:0005885; C:Arp2/3 protein complex; IDA:FlyBase. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0031941; C:filamentous actin; IEA:Ensembl. DR GO; GO:0005925; C:focal adhesion; HDA:UniProtKB. DR GO; GO:0061850; C:growth cone leading edge; IEA:Ensembl. DR GO; GO:0030027; C:lamellipodium; IDA:UniProtKB. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0035861; C:site of double-strand break; ISS:UniProtKB. DR GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW. DR GO; GO:0005200; F:structural constituent of cytoskeleton; IDA:FlyBase. DR GO; GO:0070358; P:actin polymerization-dependent cell motility; TAS:UniProtKB. DR GO; GO:0034314; P:Arp2/3 complex-mediated actin nucleation; IDA:FlyBase. DR GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl. DR GO; GO:0030833; P:regulation of actin filament polymerization; IEA:InterPro. DR Gene3D; 1.10.1760.10; Actin-related protein 2/3 complex subunit 3; 1. DR InterPro; IPR007204; ARPC3. DR InterPro; IPR036753; ARPC3_sf. DR PANTHER; PTHR12391:SF10; ACTIN-RELATED PROTEIN 2_3 COMPLEX SUBUNIT 3; 1. DR PANTHER; PTHR12391; ARP2/3 COMPLEX 21 KD SUBUNIT; 1. DR Pfam; PF04062; P21-Arc; 1. DR PIRSF; PIRSF016315; ARP2/3_P21-Arc; 1. DR SUPFAM; SSF69060; Arp2/3 complex 21 kDa subunit ARPC3; 1. DR Genevisible; O15145; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Actin-binding; Cell projection; Cytoplasm; KW Cytoskeleton; Direct protein sequencing; Isopeptide bond; Nucleus; KW Phosphoprotein; Reference proteome; Ubl conjugation. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:12665801" FT CHAIN 2..178 FT /note="Actin-related protein 2/3 complex subunit 3" FT /id="PRO_0000124042" FT MOD_RES 47 FT /note="Phosphotyrosine" FT /evidence="ECO:0007744|PubMed:19690332" FT MOD_RES 56 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:19608861" FT MOD_RES 61 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:19608861" FT CROSSLNK 14 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0007744|PubMed:28112733" FT CONFLICT 134 FT /note="Q -> P (in Ref. 1; AAB61466)" FT /evidence="ECO:0000305" SQ SEQUENCE 178 AA; 20547 MW; 7149F598B48F0EAC CRC64; MPAYHSSLMD PDTKLIGNMA LLPIRSQFKG PAPRETKDTD IVDEAIYYFK ANVFFKNYEI KNEADRTLIY ITLYISECLK KLQKCNSKSQ GEKEMYTLGI TNFPIPGEPG FPLNAIYAKP ANKQEDEVMR AYLQQLRQET GLRLCEKVFD PQNDKPSKWW TCFVKRQFMN KSLSGPGQ //